|
시장보고서
상품코드
2066266
프로바이오틱스 보충제 시장 : 제품 형태별, 유통 채널별, 최종사용자별, 건강 용도별, 성분별, 지역별 - 세계 예측(-2031년)Probiotic Supplements Market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application, End User, Distribution Channel, Ingredient (Bacteria & Yeast), and Region - Global Forecast to 2031 |
||||||
프로바이오틱스 보충제 시장 규모는 2026년 106억 달러에서 2031년까지 166억 9,000만 달러로 성장할 것으로 예상되며, CAGR은 9.5%라는 높은 성장률을 나타낼 것으로 예측됩니다.
| 조사 범위 | |
|---|---|
| 조사 대상 기간 | 2022-2031년 |
| 기준 연도 | 2025년 |
| 예측 기간 | 2026-2031년 |
| 산정 단위 | 금액(100만/10억 달러) 및 수량(1,000톤) |
| 부문 | 제품 형태별, 유통 채널별, 최종사용자별, 건강 용도별, 성분별, 지역별 |
| 대상 지역 | 북미, 유럽, 아시아태평양, 남미, 기타 지역 |
소화기 건강, 미생물군집의 균형, 면역력 강화 및 예방 의학에 대한 소비자들의 인식이 높아지면서 시장 성장을 견인하고 있습니다. 기능성 영양 제품에 대한 수요 증가와 과학에 기반한 영양 보충제로의 강력한 전환이 이러한 성장에 기여하고 있습니다.
편의성, 안정성 및 특정 건강 효능에 대한 주장을 최적화하기 위해 캡슐, 구미·씹어 먹는 제형, 분말, 정제, 액체 등 모든 제형에서 새로운 프로바이오틱스 배합 개발이 점점 더 중요시되고 있습니다. 마찬가지로, 마이크로바이옴에 대한 투자 확대, 균주 특이적 배합, 그리고 임상적으로 검증된 프로바이오틱스 원료에 대한 관심이 높아지고 있는 점도 이 분야의 제품 혁신을 더욱 촉진하고 있습니다. 또한 각 기업은 위장 건강, 면역 건강, 여성 건강, 구강 건강, 대사 건강, 소아 건강 등 다양한 용도에 대응할 수 있도록 제품 라인업을 확충하고 있습니다.
이 시장의 과제로는 건강 강조 표시에 관한 규정 등 규제상의 미묘한 차이, 생균의 안정성에 대한 우려, 임상시험 및 균주 개발과 관련된 높은 비용 등을 들 수 있습니다. 그러나 맞춤형 영양에 대한 관심이 높아지고, 온라인 채널의 이용이 확대되며, 기능성을 중시하는 웰니스 제품에 대한 수요가 증가함에 따라, 전 세계의 프로바이오틱스 보충제 제조사들에게 이는 큰 성장 기회가 되고 있습니다.
“제품 형태별로는 구미 및 츄어블이 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다.”
예측 기간 동안 프로바이오틱스 보충제 시장에서 구미 및 츄어블 제품이 가장 빠르게 성장하는 제품 형태 부문이 될 것으로 예상됩니다. 프로바이오틱스가 함유된 구미 및 씹어 먹는 정제 시장은 섭취하기 쉽고 맛이 가미된 보충제 형태에 대한 소비자의 수요가 증가함에 따라 눈부신 성장을 이루고 있습니다. 이 카테고리는 특히 어린이와 청소년층에게 인기가 많습니다.
최근 많은 기업들이 소화기 계통이나 면역 계통 지원과 같은 구조·기능 관련 건강 표시를 뒷받침하기 위해 비타민이나 미네랄 프리믹스, 프리바이오틱스를 첨가하거나 첨가하지 않은 프로바이오틱스 구미의 제형을 개발하고 있습니다. 이러한 제형은 기존의 보충제 형태에 비해 맛과 휴대성이 개선되고, 복용 순응도가 높아지는 등의 이점을 제공합니다.
프로바이오틱스 보충제 시장에서 현재 캡슐은 모든 기능성 식품 및 캡슐 제품 중에서 가장 큰 시장 점유율을 차지하고 있습니다. 이는 캡슐이 안정성이 높고, 정확한 투여가 가능하며, 보관 기간이 길고, 대부분의 성인 소비자가 섭취하기 쉽기 때문입니다. 또한, 한 번의 투여로 여러 프로바이오틱스 균주를 효과적으로 섭취할 수 있다는 점도 캡슐의 또 다른 장점이며, 그 덕분에 약국, 드럭스토어, 헬스케어 채널 등 모든 유통 채널에서 활용이 가능합니다.
“건강 용도별로는 예측 기간 동안 면역 지원 부문이 가장 빠르게 성장할 것으로 예상됩니다.”
예측 기간 동안 프로바이오틱스 보충제 시장에서 면역 지원 부문이 가장 빠르게 성장하는 건강 용도 부문이 될 것으로 예상됩니다. 면역 건강, 예방 의료, 웰니스에 대한 소비자의 인식이 높아짐에 따라, 면역 건강을 지원하도록 설계된 프로바이오틱스 보충제의 수용이 촉진되고 있습니다.
현재, 더 많은 제약사들이 장내 미생물 군집의 균형을 회복하고 더 강력한 면역 반응을 이끌어내기 위해 임상적으로 효능이 입증된 박테리아 및 효모 균주를 활용한 특수 프로바이오틱스 제제를 개발하고 있습니다. 장 건강이 면역 체계에 미치는 영향에 대한 소비자들의 이해가 깊어지고 있는 점도, 면역 기능을 지원하는 프로바이오틱스 보충제에 대한 수요 증가를 뒷받침하고 있습니다.
현재 프로바이오틱스 보충제 시장에서 가장 큰 점유율을 차지하고 있는 분야는 소화기 건강 분야이며, 이는 소화기 건강, 장내 미생물 균형, 그리고 소화 기능 지원에 대한 소비자의 관심이 점점 더 높아지고 있기 때문입니다. 프로바이오틱스 보충제는 모든 연령대의 소비자들 사이에서 소화 기능, 장 건강 및 건강한 장내 미생물 군집 유지를 촉진하기 위해 가장 널리 사용되고 있습니다.
“최종사용자별로는 예측 기간 동안 아동용 부문이 가장 빠른 성장세를 보일 것으로 예상됩니다.”
예측 기간 동안 프로바이오틱스 보충제 시장에서 어린이용 부문이 가장 빠르게 성장할 최종사용자층이 될 것으로 전망됩니다. 아이들의 장내 환경, 면역력 향상, 소화기 건강에 대한 학부모들의 관심이 높아지면서, 어린이용 프로바이오틱스 보충제의 소비가 증가하고 있습니다.
현재 각 제조사들은 어린이용 프로바이오틱스 제품에 대해 더 마시기 쉬운 맛은 물론 구미, 분말, 씹어 먹는 정제, 액상 드롭 등 섭취하기 편한 형태를 도입하고 있습니다. 예방 소아과에 대한 인식이 높아지고, 그 밖의 미생물군집을 중시하는 영양 솔루션에 대한 관심이 증가함에 따라 이 부문의 성장이 가속화되고 있습니다.
'성인' 대상 시장은 소화기 건강, 면역력 향상, 대사 건강 및 일반적인 예방 의학을 목적으로 하는 영양 보충제의 소비량이 많기 때문에 현재 프로바이오틱스 보충제 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 건강에 대한 인식이 높아지고, 근로 인구층을 중심으로 일상적인 건강 유지를 위한 건강기능식품의 이용이 확대되면서 이 부문의 성장을 이끌고 있습니다.
“아시아태평양은 예측 기간 동안 프로바이오틱스 보충제 시장에서 가장 빠르게 성장할 지역 시장이 될 것으로 전망됩니다.”
아시아태평양은 해당 지역 전체적으로 소화기 건강, 면역력 강화, 예방 의료에 대한 소비자의 인식이 높아지고 있는 만큼, 예측 기간 동안 프로바이오틱스 보충제 시장에서 가장 빠르게 성장하는 지역 시장이 될 것으로 전망됩니다. 가처분 소득의 증가, 중산층의 확대, 급속한 도시화, 그리고 식습관의 변화가 중국, 인도, 일본, 한국, 호주 등 여러 국가에서 프로바이오틱스 보충제의 보급 확대에 크게 기여하고 있습니다.
건강한 라이프스타일에 대한 소비자의 관심이 높아짐에 따라, 프로바이오틱스 캡슐, 구미, 분말, 씹어 먹는 제형, 액상 제제 등의 채택이 확대되고 있는 것이 아시아태평양 시장의 성장에 크게 기여하고 있습니다. 기능성 식품 및 영양 보충제의 채택 확대, 소매점에서의 구매 편의성 향상, E-Commerce 사이트의 보급 확대 역시 업계 전반의 성장을 뒷받침하는 요인이 되고 있습니다.
또한, 각 기업은 지역 내 시장 침투율을 높이기 위해 신제품 개발, 현지 사정에 맞춘 제형 개발, 그리고 유통 채널 확대에 막대한 투자를 하고 있습니다. 또한, 예방 의료, 소아과, 여성 건강 및 맞춤형 건강 솔루션에 대한 관심이 높아지고 있는 점도 예측 기간 동안 시장의 건전한 성장을 뒷받침할 것으로 전망됩니다.
“유통 채널별로는 예측 기간 동안 E-Commerce 부문이 가장 빠른 성장세를 보일 것으로 예상됩니다.”
예측 기간 동안 E-Commerce는 프로바이오틱스 보충제 시장에서 가장 빠르게 성장할 유통 채널 부문이 될 것으로 예상됩니다. 제품의 디지털화 진전, 건강 관련 제품의 온라인 구매 급증, 그리고 소비자들이 추구하는 편의성에 대한 선호가 프로바이오틱스 보충제의 온라인 판매 급성장을 뒷받침하고 있습니다.
소비자들은 온라인 플랫폼을 통해 더 다양한 제품 선택지, 정기 구독 옵션, 제품 비교, 고객 리뷰는 물론, 최고급 제품이나 한정판 프로바이오틱스 제품까지 연중무휴 24시간 이용할 수 있게 되었습니다. 각 제조사들은 온라인 판매의 성공을 뒷받침하기 위해 D2C(소비자 직접 판매) 방식과 디지털 마케팅 캠페인을 점점 더 적극적으로 활용하고 있습니다.
약국과 드럭스토어는 소비자들의 높은 신뢰, 제품 추천, 그리고 임상적 용도를 목적으로 한 프로바이오틱스의 폭넓은 접근성 덕분에 프로바이오틱스 보충제 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 소비자들은 여전히 약국에서 건강 관련 프로바이오틱스를 구매하고 있는 것으로 보고되고 있으며, 이러한 행동은 해당 소매업체의 신뢰성과 확실성에 힘입은 것입니다.
“성분별로는 사카로마이세스 불라르디(Saccharomyces boulardii) 부문이 예측 기간 동안 가장 빠른 성장세를 보일 것으로 예상됩니다.”
사카로마이세스 브라디는 예측 기간 동안 프로바이오틱스 보충제 시장 전체에서 가장 빠르게 성장할 성분 부문이 될 것으로 예상됩니다. 소화기 계통 및 위장 건강 관리, 그리고 항생제 사용과 관련된 소화기 계통 장애 관리에 있어 사카로마이세스 브라디의 효능을 입증하는 과학적 연구가 늘어나고 있어, 사카로마이세스 브라디를 주성분으로 한 프로바이오틱스 보충제에 대한 수요가 높아지고 있습니다.
사카로마이세스 브라디는 그 안정성, 생존성 및 다양한 보충제 형태와의 호환성 덕분에, 점점 더 많은 제조사들이 소화기 건강 및 면역력 강화를 목적으로 하는 제품에 이를 배합하고 있습니다. 또한, 임상 연구를 통해 효과가 입증된 특정 프로바이오틱스 균주에 대해 소비자들이 더 높은 정확도와 효과를 요구하게 되면서, 각 부문은 더욱 확대되고 있습니다.
현재 프로바이오틱스 보충제 시장에서 유산균이 주요 부문을 차지하고 있습니다. 이는 유산균이 소화기 건강, 면역 건강, 여성 건강, 그리고 전반적인 웰빙 등 가장 다양한 분야에서 활용되고 있기 때문입니다. 또한, 광범위한 임상적 근거와 높은 인지도, 그리고 캡슐, 분말, 구미, 액체 등 다양한 형태로 응용이 가능하다는 점 때문에 프로바이오틱스 보충제 배합에 있어 유산균 균주가 가장 많이 사용되고 있습니다.
시장의 주요 기업으로는 Nestle S.A.(스위스), Yakult Honsha(일본), Symrise AG(독일), Kerry Group plc(아일랜드), Herbalife Ltd.(영국), Morinaga Milk Industry(일본), Amway Corporation(영국), Jarrow Formulas, Inc., Biogaia(스웨덴) 등이 있습니다.
조사 범위
본 조사 보고서에서는 프로바이오틱스 보충제 시장을 제품 형태(정제, 캡슐, 분말, 구미·츄어블, 액상, 기타 제품 형태), 건강 용도(소화기 건강, 면역 지원, 여성 건강, 대사 건강, 장내 환경 건강, 구강 건강, 기타 건강 용도), 최종사용자(영유아, 소아, 성인, 고령자), 유통 채널(하이퍼마켓/슈퍼마켓, 약국/드럭스토어, 전문점, E-Commerce, 기타 유통 채널), 성분(세균(락토바실러스, 비피도박테리움, 바실러스, 스트렙토코커스 테르모필루스) 및 효모(사카로마이세스 블라디, 기타 효모)), 그리고 지역(북미, 유럽, 아시아태평양, 남미 및 기타 지역)입니다.
본 보고서의 조사 범위에는 프로바이오틱스 보충제 산업의 성장에 영향을 미치는 주요 요인(촉진요인, 제약요인, 과제 및 기회 등)에 대한 상세한 정보가 포함되어 있습니다. 주요 업계 업체에 대한 철저한 분석을 통해 해당 업체의 사업, 서비스, 주요 전략, 계약, 파트너십, 합의 사항, 신규 서비스 출시, 합병 및 인수, 그리고 프로바이오틱스 보충제 시장과 관련된 최근 동향에 대한 인사이트를 제공합니다. 본 보고서에서는 프로바이오틱스 보충제 시장의 생태계에서 두각을 나타내고 있는 스타트업 기업들에 대한 경쟁 분석도 수록하고 있습니다. 또한, 본 조사에서는 기술 분석, 생태계 및 시장 매핑, 특허·규제 현황 등 업계 특유의 동향에 대해서도 포괄적으로 다루고 있습니다.
이 보고서를 구매해야 하는 이유
본 보고서는 시장 선도 기업 및 신규 진입 기업을 대상으로, 프로바이오틱스 보충제 시장 전체 및 그 하위 부문의 매출에 대한 가장 정확한 추정치를 제공합니다. 이를 통해 이해관계자들은 경쟁 구도를 파악하고, 더 깊은 인사이트를 얻어 자사의 비즈니스를 적절히 포지셔닝하며, 적절한 시장 진입 전략을 수립하는 데 도움이 됩니다. 또한, 본 보고서는 이해관계자들이 시장 동향을 파악하는 데 도움이 되며, 주요 시장 촉진요인, 억제요인, 과제 및 기회에 관한 정보를 제공합니다.
본 보고서에서는 다음 사항에 대한 인사이트를 제공합니다:
- 프로바이오틱스 보충제 시장의 성장에 영향을 미치는 주요 시장 촉진요인(소화기 건강 및 면역력 지원에 대한 소비자 인식 제고), 제약요인(프로바이오틱스 균주와 관련된 안정성 및 유통기한 문제), 기회(맞춤형 영양 및 표적형 프로바이오틱스 제제의 확대), 그리고 과제(여러 프로바이오틱스 균주를 아우르는 제제의 복잡성 관리)에 대한 분석
- 제품 개발/혁신 : 프로바이오틱스 보충제 시장의 연구개발 활동 및 신제품 출시에 대한 상세한 분석
- 시장 개발 : 다양한 지역의 프로바이오틱스 보충제 수익성 높은 시장에 대한 종합적인 분석 정보
- 시장의 다양화 : 프로바이오틱스 보충제 시장의 신제품 공급원, 미개척 지역, 최근 동향 및 투자에 관한 종합적인 정보
- 경쟁사 분석 : Nestle S.A.(스위스), Yakult Honsha(일본), Symrise AG(독일), Kerry Group plc(아일랜드), Herbalife Ltd.(영국), Morinaga Milk Industry(일본), Amway Corporation(영국), Jarrow Formulas, Inc.(영국), Biogaia(스웨덴), Metagenics, Inc.(영국), OptiBiotix Health Plc(영국), Nature's Way Products, LLC(영국), Optibac Probiotics Ltd.(영국), AB-BIOTICS S.A.(스페인), Lifeway Foods, Inc.(영국) 및 기타 프로바이오틱스 보충제 시장의 주요 기업들을 다루고 있습니다.
자주 묻는 질문
목차
제1장 소개
제2장 주요 요약
제3장 주요 인사이트
제4장 시장 개요
제5장 업계 동향
제6장 기술의 진보, AI에 의한 영향, 특허, 혁신, 그리고 향후 응용
제7장 규제 상황과 지속가능성에 대한 대처
제8장 고객 상황과 구매 행동
제9장 프로바이오틱스 보충제 시장(제품 형태별)
제10장 프로바이오틱스 보충제 시장(유통 채널별)
제11장 프로바이오틱스 보충제 시장(최종사용자별)
제12장 프로바이오틱스 보충제 시장(건강 용도별)
제13장 프로바이오틱스 보충제 시장(성분별)
제14장 프로바이오틱스 보충제 시장(지역별)
제15장 경쟁 구도
제16장 기업 개요
제17장 조사 방법
제18장 인접 시장 및 관련 시장
제19장 부록
KSM 26.06.30The probiotic supplements market is projected to expand from USD 10.60 billion in 2026 to USD 16.69 billion by 2031, at a high CAGR of 9.5%.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion) and Volume (KT) |
| Segments | Product Form, Health Application, End User, Distribution Channel, Ingredient, and Region |
| Regions covered | North America, Europe, Asia Pacific, South America, RoW |
Consumer awareness of digestive health, microbiome balance, immune support, and preventive healthcare consumption is driving market growth. Increasing demand for functional nutrition products and a strong shift towards science-based dietary supplements are contributing to this growth.
There is an increased emphasis on developing novel probiotic formulas across all format types, including capsules, gummies & chewable, powders, tablets, and liquids to optimize convenience, stability and targeted health claims. Likewise, a boost to microbiome investment, strain-specific formulations, and clinically validated probiotic ingredients is further driving product innovation in this space. Companies are also broadening their product ranges to support multiple applications such as gastrointestinal health, immune health, women's health, oral health, metabolic health and pediatric health.
Challenges in this market include regulatory nuances, such as stipulations on health claims, concerns about the stability of live organisms, and the high costs related to clinical trials and strain development. However, the increasing trend towards customized nutrition, the growing use of electronic channels, and the demand for functionally driven wellness products present significant growth opportunities for probiotic supplement manufacturers worldwide.
"By product form, gummies & chewables are expected to be the fastest-growing segment during the forecast period."
Gummies and chewables are expected to be the fastest-growing product form segment in the probiotic supplements market during the forecast period. The market for probiotic gummies and chewables has been experiencing significant growth due to rising consumer demand for easy-to-eat, flavored supplement forms. This category is especially favored by children and younger populations.
Recently, many companies have been developing probiotic gummy formulas with or without added vitamins and mineral premixes and prebiotics to support structure/function health claims such as digestive and immune system support. These formulas offer benefits such as improved mouthfeel, portability, and better compliance compared with traditional supplement forms.
Capsules currently have the largest market share among all functional food/capsule products in the probiotic supplements market. This is because capsules are highly stable, provide accurate dosing, have a longer shelf life, and are easy for most adult consumers to take. Successfully delivering multiple probiotic strains in a single dosage form is also an additional benefit of capsules, and hence their applicability across all channels of distribution, such as pharmacies, drugstores, and healthcare channels, among others.
"By health application, immunity support is expected to be the fastest-growing segment during the forecast period."
Immunity support is expected to be the fastest-growing health application segment in the probiotic supplements market during the forecast period. Rising consumer awareness of immune health, preventive healthcare, and wellness is a major factor fueling the acceptance of probiotic supplements designed to support immune health.
More manufacturers are now creating specialized probiotic formulations with clinically validated strains of bacteria and yeast to help restore the balance of the gut microbiome and achieve a stronger immune response. Growing consumer knowledge of the impact of gut health on the immune system is also driving an increased demand for probiotic supplements targeted at immunity.
Digestive health currently accounts for the largest share of the probiotic supplement market, driven by ever-increasing consumer awareness of digestive health, gut flora balance, and digestive support. Probiotic supplements are most commonly used to enhance digestion, intestinal health, and healthy gut flora across consumers of all age groups.
"By end user, the children segment is expected to witness the fastest growth during the forecast period."
Children are anticipated to be the fastest-growing end-user segment in the probiotic supplements market during the forecast period. Rising parental awareness about children's gut health, immunity building, and digestive health is boosting the consumption of probiotic supplements among children.
Manufacturers are now leveraging more pleasant taste profiles and more convenient administration forms (such as gummies, powders, chewables, and liquid drops) of child-friendly probiotics in the form of probiotic products. Rising awareness of preventive pediatrics, as well as other microbiome-centric nutrition solutions, has accelerated segment growth.
The application 'adults' now captures the largest market share in the probiotic supplements market on account of high consumption of dietary supplements targeted at digestive health, immune system boosting, metabolic health and general preventive healthcare. Increasing health consciousness and growing use of daily wellness supplements by working population segments are driving the segment growth.
"Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period."
Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period, owing to increasing consumer awareness regarding digestive wellness, immunity support, and preventive healthcare across the region. Rising disposable incomes, expanding middle-class population, rapid urbanization, and changing dietary habits are significantly contributing to the growing adoption of probiotic supplements in countries such as China, India, Japan, South Korea, and Australia.
Growing consumer inclination toward healthy lifestyles, leading to enhanced adoption of probiotic capsules, gummies, powders, chewable, and liquid formulae, is significantly contributing to the expansion of the Asia Pacific market. Increasing adoption of functional foods and dietary supplements, wider retail availability, and growing penetration of e-commerce sites are other factors adding to the overall industry growth.
In addition, companies are investing heavily in new product development, local formulations and broadening of distribution channels to increase their regional penetration. Additionally, rising emphasis on preventive care, pediatrics, women 's health and customized health solutions is anticipated to support healthy growth in the market over the forecast period.
"By distribution channel, the E-commerce segment is expected to witness the fastest growth during the forecast period."
E-commerce is expected to be the fastest-growing distribution channel segment of the probiotic supplements market during the forecast period. The rise in product digitization, the surge in online purchasing of health products, and consumers' inclination toward ease of shopping are supporting the rapid growth of online sales of probiotic supplements.
Consumers have more choices of products, subscription purchase options, product comparisons, customer reviews, and even 24/7 access to the most premium and limited-edition probiotic products through online platforms. Producers are increasingly using direct-to-consumer approaches and digital marketing campaigns to boost their success in online sales.
Pharmacies and drugstores have the largest market share in the probiotic supplements market due to high consumer trust, product recommendations, and the wide availability of probiotics positioned for clinical use. Customers continue to report buying health-related probiotics at the pharmacy, and this behavior is supported by the credibility and reliability of these retailers.
"By ingredient, the Saccharomyces boulardii segment is expected to witness the fastest growth during the forecast period."
Saccharomyces boulardii is expected to be the fastest-growing ingredient segment during the forecast period across the probiotic supplements market. Because there is more scientific research supporting the efficacy of Saccharomyces boulardii in managing digestive and gastrointestinal health and antibiotic-associated digestive disorders, the demand for Saccharomyces boulardii-based probiotic supplements is on the increase.
As a result of its stability, survivability and compatibility with a wide variety of supplement formats, Saccharomyces boulardii is being integrated into targeted digestive health and immunity support products by an increasing number of manufacturers. Segments are further expanding as consumers demand higher levels of accuracy and strength associated with specific probiotic strains that offer proven benefits according to clinical studies.
Lactobacilli represent the dominant segment of the probiotic supplements market currently. This is due to their presence in the largest number of applications, including digestive health, immune health, women 's health and general wellness. Moreover, strains of lactobacilli are the most utilized in probiotic supplement formulations because of the widespread clinical support, high awareness, and applications in capsule, powder, gummy and liquid formats.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Probiotic supplements market.
- By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
- By Designation: CXOs - 25%, Managers - 35%, Others - 40%
- By Region: North America - 20%, Europe - 30%, Asia Pacific - 35%, South America - 10%, and Rest of the World -5%
Prominent companies in the market include Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc., Biogaia (Sweden), and others.
Research Coverage
This research report categorizes the probiotic supplements market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application (Digestive Health, Immunity Support, Women's Health, Metabolic Health, Gut Health, Oral Health, and Other Health Applications), End User (Infant, Children, Adults, and Geriatric Population), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, E-commerce, and Other Distribution Channel), Ingredient (Bacteria (Lactobacilli, Bifidobacterium, Bacillus, Streptococcus Thermophilus) and Yeast (Saccharomyces Boulardii, Other Yeasts)), and Region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the Probiotic supplements industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Probiotic supplements market. This report provides a competitive analysis of emerging startups in the Probiotic supplements market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Probiotic supplements and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (Increasing consumer awareness regarding digestive health and immunity support for Probiotic supplements), restraints (Stability and shelf-life challenges associated with probiotic strains), opportunities (Expansion of personalized nutrition and targeted probiotic formulations), and challenges (Managing formulation complexity across multiple probiotic strains), influencing the growth of the probiotic supplements market
- Product Development/Innovation: Detailed insights into research & development activities and new product launches in the Probiotic supplements market
- Market Development: Comprehensive information about the lucrative market analysis of probiotic supplements across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Probiotic supplements market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc. (UK), BioGaia (Sweden), Metagenics, Inc. (UK), OptiBiotix Health Plc (UK), Nature's Way Products, LLC (UK), Optibac Probiotics Ltd. (UK), AB-BIOTICS S.A. (Spain), Lifeway Foods, Inc. (UK), and other players in the probiotic supplements market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE AND SEGMENTATION
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.4 YEARS CONSIDERED
- 1.5 CURRENCY CONSIDERED
- 1.6 STAKEHOLDERS
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN PROBIOTIC SUPPLEMENTS MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET
- 3.2 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM AND REGION
- 3.3 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT
- 3.4 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
- 3.5 PROBIOTIC SUPPLEMENTS MARKET, BY END USER
- 3.6 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION
- 3.7 PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising prevalence of digestive health disorders and gastrointestinal diseases
- 4.2.1.2 Growing consumer focus on preventive healthcare and wellness
- 4.2.1.3 Increasing scientific evidence supporting microbiome health benefits
- 4.2.2 RESTRAINTS
- 4.2.2.1 Regulatory complexities and health claim restrictions
- 4.2.2.2 Stability and shelf-life challenges of live probiotic organisms
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expansion of personalized nutrition and microbiome-based supplementation
- 4.2.3.2 Innovation in delivery formats like gummies, chewables, and stick packs
- 4.2.4 CHALLENGES
- 4.2.4.1 Scientific debate and inconsistent clinical outcomes across strains
- 4.2.4.2 Regulatory restrictions on health claims and marketing communications
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET
- 4.3.1.1 Improved probiotic survivability and delivery efficiency
- 4.3.1.2 Cost-effective and scalable solutions for emerging markets
- 4.3.1.3 Stronger clinical validation and healthcare adoption
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.3.2.1 Women's microbiome and hormonal health solutions
- 4.3.2.2 Postbiotic and next-generation microbiome products
- 4.3.2.3 Probiotic supplements for mental wellness and the gut-brain axis
- 4.3.2.4 Personalized digital microbiome ecosystems
- 4.3.1 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
- 4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 THREAT OF NEW ENTRANTS
- 5.2 MACROECONOMICS OUTLOOK
- 5.2.1 RISING GLOBAL POPULATION AND INCREASING DEMAND FOR PREVENTIVE HEALTHCARE
- 5.2.2 EXPANSION OF E-COMMERCE AND DIGITAL HEALTH ECOSYSTEMS
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.3.1 UPSTREAM (RAW MATERIALS & INGREDIENT SUPPLIERS)
- 5.3.2 INGREDIENT PROCESSING & MANUFACTURING
- 5.3.3 SUPPLEMENT MANUFACTURING & FORMULATION
- 5.3.4 DISTRIBUTION & COMMERCIALIZATION
- 5.3.5 END USERS
- 5.3.6 SUPPORTING ECOSYSTEM
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT FORM
- 5.5.2 AVERAGE SELLING PRICE, BY REGION
- 5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 300490)
- 5.6.2 EXPORT SCENARIO (HS CODE 300490)
- 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.9 INVESTMENT AND FUNDING SCENARIO
- 5.10 CASE STUDY ANALYSIS
- 5.10.1 PENDULUM THERAPEUTICS INTRODUCED GLUCOSE CONTROL PROBIOTIC FOR METABOLIC HEALTH
- 5.10.2 NESTLE HEALTH SCIENCE LAUNCHED PERSONALIZED NUTRITION PLATFORM TO SUPPORT GUT HEALTH
- 5.11 IMPACT OF 2025 US TARIFF - PROBIOTIC SUPPLEMENTS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRIES/REGIONS
- 5.11.4.1 US
- 5.11.4.2 Europe
- 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
- 5.11.6 US TARIFF UPDATE (2026) AND LEGAL DEVELOPMENTS
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY TECHNOLOGIES
- 6.1.1 MICROENCAPSULATION
- 6.1.2 GENOMIC & METAGENOMIC SEQUENCING
- 6.1.3 LYOPHILIZATION (FREEZE-DRYING)
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 AI-DRIVEN PERSONALIZATION & DIGITAL HEALTH INTEGRATION
- 6.2.2 COLD-CHAIN INNOVATION & ADVANCED STABILITY LOGISTICS
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 PRECISION FERMENTATION
- 6.3.2 SYNTHETIC BIOLOGY & STRAIN ENGINEERING
- 6.4 TECHNOLOGY ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 INTRODUCTION
- 6.5.2 LIST OF MAJOR PATENTS, MARCH 2020-DECEMBER 2024
- 6.6 FUTURE APPLICATIONS
- 6.6.1 PERSONALIZED MICROBIOME-BASED NUTRITION
- 6.6.2 MENTAL WELLNESS AND GUT-BRAIN HEALTH
- 6.6.3 WOMEN'S HEALTH SOLUTIONS
- 6.6.4 LIVE BIOTHERAPEUTIC PRODUCTS (LBPS)
- 6.6.5 AI-ENABLED PERSONALIZED PROBIOTIC ECOSYSTEMS
- 6.7 IMPACT OF AI/GEN AI ON PROBIOTIC SUPPLEMENTS INDUSTRY
- 6.7.1 TOP USE CASES AND MARKET POTENTIALS
- 6.7.2 BEST PRACTICES IN PROBIOTIC SUPPLEMENTS INDUSTRY
- 6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PROBIOTIC SUPPLEMENTS MARKET
- 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PROBIOTIC SUPPLEMENTS MARKET
- 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
- 6.8.1 DSM-FIRMENICH: AI4B.IO FOR BIOSCIENCE INNOVATION
- 6.8.2 NESTLE HEALTH SCIENCE: PERSONALIZED NUTRITION PLATFORM
- 6.8.3 VIOME: AI-POWERED MICROBIOME PERSONALIZATION
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY FRAMEWORK
- 7.1.1.1 North America
- 7.1.1.1.1 US
- 7.1.1.1.2 Canada
- 7.1.1.1.3 Mexico
- 7.1.1.2 Europe
- 7.1.1.2.1 Germany
- 7.1.1.2.2 UK
- 7.1.1.2.3 France
- 7.1.1.2.4 Italy
- 7.1.1.2.5 Spain
- 7.1.1.2.6 Rest of Europe
- 7.1.1.3 Asia Pacific
- 7.1.1.3.1 China
- 7.1.1.3.2 India
- 7.1.1.3.3 Japan
- 7.1.1.3.4 South Korea
- 7.1.1.3.5 Australia & New Zealand
- 7.1.1.3.6 Rest of Asia Pacific
- 7.1.1.4 South America
- 7.1.1.4.1 Brazil
- 7.1.1.4.2 Rest of South America
- 7.1.1.5 RoW
- 7.1.1.5.1 Middle East Region
- 7.1.1.5.2 Africa Region
- 7.1.1.1 North America
- 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.3 INDUSTRY STANDARDS
- 7.1.4 DOCUMENTATION REQUIREMENTS
- 7.1.5 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
- 7.1.1 REGULATORY FRAMEWORK
- 7.2 SUSTAINABILITY INITIATIVES
- 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
- 7.3.1 CERTIFICATIONS, LABELING, ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
- 8.5.1 REVENUE POTENTIAL
- 8.5.2 COST DYNAMICS
- 8.5.3 MARGIN OPPORTUNITIES, BY PRODUCT FORMAT
9 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM
- 9.1 INTRODUCTION
- 9.2 TABLETS & SOFTGELS
- 9.2.1 CONVENIENT DOSAGE FORMAT SUPPORTING DEMAND FOR PROBIOTIC TABLET SUPPLEMENTS
- 9.3 CAPSULES
- 9.3.1 HIGH STABILITY AND STRAIN PROTECTION DRIVING DEMAND FOR PROBIOTIC CAPSULES
- 9.4 POWDER
- 9.4.1 FLEXIBLE DOSING AND PEDIATRIC APPLICATIONS DRIVING DEMAND FOR PROBIOTIC POWDER FORMULATIONS
- 9.5 GUMMIES & CHEWABLES
- 9.5.1 INCREASING FOCUS ON PALATABLE AND CONSUMER-FRIENDLY SUPPLEMENTS DRIVING GUMMY PROBIOTIC DEMAND
- 9.6 LIQUID
- 9.6.1 RAPID ABSORPTION AND PEDIATRIC SUITABILITY SUPPORTING DEMAND FOR LIQUID PROBIOTIC FORMULATIONS
- 9.7 OTHER PRODUCT FORMS
10 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
- 10.1 INTRODUCTION
- 10.2 HYPERMARKETS/SUPERMARKETS
- 10.2.1 HIGH PRODUCT VISIBILITY AND CONSUMER ACCESSIBILITY SUPPORTING PROBIOTIC SALES THROUGH MODERN RETAIL CHANNELS
- 10.3 PHARMACIES/DRUGSTORES
- 10.3.1 STRONG CONSUMER TRUST AND HEALTHCARE-ORIENTED PURCHASING DRIVING PROBIOTIC SALES THROUGH PHARMACIES
- 10.4 SPECIALTY STORES
- 10.4.1 RISING POPULARITY OF PREMIUM AND TARGETED NUTRITION PRODUCTS DRIVING GROWTH OF SPECIALTY HEALTH STORES
- 10.5 E-COMMERCE
- 10.5.1 RAPID DIGITALIZATION AND ONLINE WELLNESS PURCHASING FUELING EXPANSION OF E-COMMERCE CHANNELS
- 10.6 OTHER DISTRIBUTION CHANNELS
11 PROBIOTIC SUPPLEMENTS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 INFANTS
- 11.2.1 INCREASING FOCUS ON EARLY-LIFE MICROBIOME DEVELOPMENT DRIVING DEMAND FOR INFANT PROBIOTIC SUPPLEMENTS
- 11.3 CHILDREN
- 11.3.1 RISING PARENTAL AWARENESS REGARDING PEDIATRIC IMMUNITY AND DIGESTIVE WELLNESS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS
- 11.4 ADULTS
- 11.4.1 INCREASING PREVALENCE OF LIFESTYLE-RELATED HEALTH CONDITIONS SUPPORTING ADULT PROBIOTIC CONSUMPTION
- 11.5 GERIATRIC POPULATION
- 11.5.1 GROWING AGING POPULATION AND DIGESTIVE HEALTH CONCERNS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS AMONG GERIATRIC CONSUMERS
12 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION
- 12.1 INTRODUCTION
- 12.2 DIGESTIVE HEALTH
- 12.2.1 GROWING PREVALENCE OF GASTROINTESTINAL DISORDERS SUPPORTING DEMAND FOR DIGESTIVE HEALTH PROBIOTIC SUPPLEMENTS
- 12.3 IMMUNITY SUPPORT
- 12.3.1 INCREASING FOCUS ON IMMUNE RESILIENCE DRIVING ADOPTION OF IMMUNITY SUPPORT PROBIOTIC SUPPLEMENTS
- 12.4 WOMEN'S HEALTH
- 12.4.1 RISING FOCUS ON VAGINAL, URINARY, AND HORMONAL WELLNESS DRIVING DEMAND FOR WOMEN'S HEALTH PROBIOTIC SUPPLEMENTS
- 12.5 METABOLIC HEALTH
- 12.5.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISORDERS SUPPORTING DEMAND FOR METABOLIC HEALTH PROBIOTIC SUPPLEMENTS
- 12.6 ORAL HEALTH
- 12.6.1 RISING PREVALENCE OF DENTAL CARIES, GINGIVITIS, AND ORAL MICROBIOME IMBALANCE DRIVING DEMAND FOR ORAL HEALTH PROBIOTIC SUPPLEMENTS
- 12.7 OTHER HEALTH APPLICATIONS
13 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT
- 13.1 INTRODUCTION
- 13.2 BACTERIA
- 13.2.1 STRONG CLINICAL VALIDATION AND WIDESPREAD DIGESTIVE HEALTH APPLICATIONS SUPPORTING BACTERIAL PROBIOTIC DOMINANCE
- 13.2.2 LACTOBACILLI
- 13.2.3 BIFIDOBACTERIUM
- 13.2.4 BACILLUS
- 13.2.5 STREPTOCOCCUS THERMOPHILUS
- 13.3 YEAST
- 13.3.1 INCREASING UTILIZATION OF STABLE MICROORGANISM STRAINS SUPPORTING YEAST-BASED PROBIOTICS DEMAND
- 13.3.2 SACCHAROMYCES BOULARDII
- 13.3.3 OTHER YEASTS
14 PROBIOTIC SUPPLEMENTS MARKET, BY REGION
- 14.1 INTRODUCTION
- 14.2 NORTH AMERICA
- 14.2.1 US
- 14.2.1.1 Strong microbiome health awareness and high functional supplement adoption to drive market
- 14.2.2 CANADA
- 14.2.2.1 Growing functional food consumption and strong regulatory oversight to support market growth
- 14.2.3 MEXICO
- 14.2.3.1 Rising health awareness and expanding functional nutrition demand to support market development
- 14.2.1 US
- 14.3 EUROPE
- 14.3.1 GERMANY
- 14.3.1.1 Strong dietary supplement industry and increasing preventive healthcare awareness to support market growth
- 14.3.2 UK
- 14.3.2.1 Expanding e-commerce healthcare retail and growing gut health awareness to drive market
- 14.3.3 FRANCE
- 14.3.3.1 Strong preventive healthcare culture and scientific engagement to support market expansion
- 14.3.4 SPAIN
- 14.3.4.1 Growing consumer awareness and increasing digestive health focus to support market growth
- 14.3.5 ITALY
- 14.3.5.1 High consumer familiarity with probiotics and strong pharmacy distribution channels to support market expansion
- 14.3.6 REST OF EUROPE
- 14.3.1 GERMANY
- 14.4 ASIA PACIFIC
- 14.4.1 CHINA
- 14.4.1.1 Growing digestive health awareness and expanding nutraceutical industry to drive market
- 14.4.2 JAPAN
- 14.4.2.1 High consumer awareness regarding gut health and strong healthy aging demand to support market expansion
- 14.4.3 SOUTH KOREA
- 14.4.3.1 Strong functional nutrition culture and expanding online supplement sales to support market growth
- 14.4.4 INDIA
- 14.4.4.1 Rising digestive health concerns and expanding nutraceutical industry to drive market
- 14.4.5 AUSTRALIA & NEW ZEALAND
- 14.4.5.1 Strong preventive healthcare culture and high supplement consumption to support market expansion
- 14.4.6 REST OF ASIA PACIFIC
- 14.4.1 CHINA
- 14.5 SOUTH AMERICA
- 14.5.1 BRAZIL
- 14.5.1.1 Large consumer base, expanding dietary supplement industry, and rising gut health awareness to support market growth
- 14.5.2 ARGENTINA
- 14.5.2.1 Increasing healthcare awareness and growing preventive nutrition adoption to support market expansion
- 14.5.3 REST OF SOUTH AMERICA
- 14.5.1 BRAZIL
- 14.6 REST OF THE WORLD
- 14.6.1 MIDDLE EAST
- 14.6.1.1 High healthcare expenditure, rising lifestyle-related diseases, and growing wellness consumption to drive market
- 14.6.2 AFRICA
- 14.6.2.1 Rising healthcare awareness, growing digestive health concerns, and expanding pharmacy retail infrastructure to drive market
- 14.6.1 MIDDLE EAST
15 COMPETITIVE LANDSCAPE
- 15.1 OVERVIEW
- 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2026
- 15.3 REVENUE ANALYSIS, 2023-2025
- 15.4 MARKET SHARE ANALYSIS, 2025
- 15.5 BRAND COMPARISON
- 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 15.6.1 STARS
- 15.6.2 EMERGING LEADERS
- 15.6.3 PERVASIVE PLAYERS
- 15.6.4 PARTICIPANTS
- 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 15.6.5.1 Company footprint
- 15.6.5.2 Region footprint
- 15.6.5.3 Health application footprint
- 15.6.5.4 Product form footprint
- 15.6.5.5 End user footprint
- 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 15.7.1 PROGRESSIVE COMPANIES
- 15.7.2 RESPONSIVE COMPANIES
- 15.7.3 DYNAMIC COMPANIES
- 15.7.4 STARTING BLOCKS
- 15.7.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
- 15.7.5.1 Detailed list of key startups/SMEs
- 15.7.5.2 Competitive benchmarking of key startups/SMEs
- 15.8 COMPANY VALUATION AND FINANCIAL METRICS
- 15.8.1 COMPANY VALUATION
- 15.8.2 EV/EBITDA
- 15.9 COMPETITIVE SCENARIO
- 15.9.1 PRODUCT LAUNCHES
- 15.9.2 DEALS
- 15.9.3 EXPANSIONS
16 COMPANY PROFILES
- 16.1 KEY PLAYERS
- 16.1.1 NESTLE S.A.
- 16.1.1.1 Business overview
- 16.1.1.2 Products/Solutions/Services offered
- 16.1.1.3 Recent developments
- 16.1.1.3.1 Deals
- 16.1.1.4 MnM view
- 16.1.1.4.1 Right to win
- 16.1.1.4.2 Strategic choices
- 16.1.1.4.3 Weaknesses and competitive threats
- 16.1.2 YAKULT HONSHA CO., LTD.
- 16.1.2.1 Business overview
- 16.1.2.2 Products/Solutions/Services offered
- 16.1.2.3 Recent developments
- 16.1.2.3.1 Product launches
- 16.1.2.3.2 Deals
- 16.1.2.4 MnM view
- 16.1.2.4.1 Right to win
- 16.1.2.4.2 Strategic choices
- 16.1.2.4.3 Weaknesses and competitive threats
- 16.1.3 BIOGAIA
- 16.1.3.1 Business overview
- 16.1.3.2 Products/Solutions/Services offered
- 16.1.3.3 Recent developments
- 16.1.3.3.1 Product launches
- 16.1.3.3.2 Deals
- 16.1.3.4 MnM view
- 16.1.3.4.1 Right to win
- 16.1.3.4.2 Strategic choices
- 16.1.3.4.3 Weaknesses and competitive threats
- 16.1.4 KERRY GROUP PLC
- 16.1.4.1 Business overview
- 16.1.4.2 Products/Solutions/Services offered
- 16.1.4.3 Recent developments
- 16.1.4.3.1 Deals
- 16.1.4.4 MnM view
- 16.1.4.4.1 Right to win
- 16.1.4.4.2 Strategic choices
- 16.1.4.4.3 Weaknesses and competitive threats
- 16.1.5 AMWAY
- 16.1.5.1 Business overview
- 16.1.5.2 Products/Solutions/Services offered
- 16.1.5.3 Recent developments
- 16.1.5.3.1 Product launches
- 16.1.5.4 MnM view
- 16.1.5.4.1 Right to win
- 16.1.5.4.2 Strategic choices
- 16.1.5.4.3 Weaknesses and competitive threats
- 16.1.6 NATURE'S WAY
- 16.1.6.1 Business overview
- 16.1.6.2 Products/Solutions/Services offered
- 16.1.6.3 Recent developments
- 16.1.6.3.1 Expansions
- 16.1.6.4 MnM view
- 16.1.7 HERBALIFE LTD.
- 16.1.7.1 Business overview
- 16.1.7.2 Products/Solutions/Services offered
- 16.1.7.3 Recent developments
- 16.1.7.3.1 Deals
- 16.1.7.4 MnM view
- 16.1.8 MORINAGA MILK INDUSTRY CO., LTD.
- 16.1.8.1 Business overview
- 16.1.8.2 Products/Solutions/Services offered
- 16.1.8.3 Recent developments
- 16.1.8.3.1 Deals
- 16.1.8.4 MnM view
- 16.1.9 JARROW FORMULAS, INC.
- 16.1.9.1 Business overview
- 16.1.9.2 Products/Solutions/Services offered
- 16.1.9.3 Recent developments
- 16.1.9.3.1 Product launches
- 16.1.9.3.2 Deals
- 16.1.9.4 MnM view
- 16.1.10 SYMRISE AG
- 16.1.10.1 Business overview
- 16.1.10.2 Products/Solutions/Services offered
- 16.1.10.3 Recent developments
- 16.1.10.3.1 Product launches
- 16.1.10.4 MnM view
- 16.1.11 METAGENICS, INC.
- 16.1.11.1 Business overview
- 16.1.11.2 Products/Solutions/Services offered
- 16.1.11.3 Recent developments
- 16.1.11.3.1 Deals
- 16.1.11.4 MnM view
- 16.1.12 OPTIBIOTIX HEALTH PLC
- 16.1.12.1 Business overview
- 16.1.12.2 Products/Solutions/Services offered
- 16.1.12.3 Recent developments
- 16.1.12.4 MnM view
- 16.1.13 OPTIBAC PROBIOTICS LTD.
- 16.1.13.1 Business overview
- 16.1.13.2 Products/Solutions/Services offered
- 16.1.13.3 Recent developments
- 16.1.13.3.1 Product launches
- 16.1.13.4 MnM view
- 16.1.14 AB-BIOTICS S.A.
- 16.1.14.1 Business overview
- 16.1.14.2 Products/Solutions/Services offered
- 16.1.14.3 Recent developments
- 16.1.14.3.1 Deals
- 16.1.14.4 MnM view
- 16.1.15 LIFEWAY FOODS, INC.
- 16.1.15.1 Business overview
- 16.1.15.2 Products/Solutions/Services offered
- 16.1.15.3 Recent developments
- 16.1.15.4 MnM view
- 16.1.1 NESTLE S.A.
- 16.2 STARTUPS/SMES
- 16.2.1 SEED HEALTH, INC.
- 16.2.1.1 Business overview
- 16.2.1.2 Products/Solutions/Services offered
- 16.2.1.3 Recent developments
- 16.2.1.3.1 Product launches
- 16.2.1.4 MnM view
- 16.2.2 PENDULUM THERAPEUTICS
- 16.2.2.1 Business overview
- 16.2.2.2 Products/Solutions/Services offered
- 16.2.2.3 Recent developments
- 16.2.2.3.1 Product launches
- 16.2.2.3.2 Deals
- 16.2.2.4 MnM view
- 16.2.3 FLORE INC.
- 16.2.3.1 Business overview
- 16.2.3.2 Products/Solutions/Services offered
- 16.2.3.3 Recent developments
- 16.2.3.4 MnM view
- 16.2.4 CUSTOM PROBIOTICS INC.
- 16.2.4.1 Business overview
- 16.2.4.2 Products/Solutions/Services offered
- 16.2.4.3 Recent developments
- 16.2.4.4 MnM view
- 16.2.5 ORA ORGANIC
- 16.2.5.1 Business overview
- 16.2.5.2 Products/Solutions/Services offered
- 16.2.5.3 Recent developments
- 16.2.5.4 MnM view
- 16.2.6 LOVEBUG PROBIOTICS
- 16.2.7 BIOHM HEALTH
- 16.2.8 TONIIQ
- 16.2.9 FITBIOMICS
- 16.2.10 RESBIOTIC NUTRITION
- 16.2.1 SEED HEALTH, INC.
17 RESEARCH METHODOLOGY
- 17.1 RESEARCH DATA
- 17.1.1 SECONDARY DATA
- 17.1.1.1 Key data from secondary sources
- 17.1.2 PRIMARY DATA
- 17.1.2.1 Key data from primary sources
- 17.1.2.2 Breakdown of primary profiles
- 17.1.2.3 Key insights from industry experts
- 17.1.1 SECONDARY DATA
- 17.2 MARKET SIZE ESTIMATION
- 17.2.1 SUPPLY SIDE
- 17.3 DATA TRIANGULATION
- 17.4 RESEARCH ASSUMPTIONS
- 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
18 ADJACENT & RELATED MARKETS
- 18.1 INTRODUCTION
- 18.2 LIMITATIONS
- 18.3 NUTRACEUTICAL INGREDIENTS MARKET
- 18.3.1 MARKET DEFINITION
- 18.3.2 MARKET OVERVIEW
- 18.4 PROBIOTICS MARKET
- 18.4.1 MARKET DEFINITION
- 18.4.2 MARKET OVERVIEW
19 APPENDIX
- 19.1 DISCUSSION GUIDE
- 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 19.3 CUSTOMIZATION OPTIONS
- 19.4 RELATED REPORTS
- 19.5 AUTHOR DETAILS
